Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is granulosa cell tumor of the ovary?
Granulosa cell tumors are an uncommon kind of ovarian tumor that grow from the ovary's hormone-producing support cells (the 'granulosa' cells that normally surround a developing egg), rather than from egg cells themselves. They belong to the 'sex cord-stromal' family of ovarian tumors. Many of them make estrogen, which can cause symptoms that lead to the diagnosis — such as unusual vaginal bleeding, a return of bleeding after menopause, or, in young girls, early puberty. They tend to grow slowly and are usually found while still confined to one ovary, where surgery alone often cures them. A hallmark of this tumor is that it can recur years or even decades after the first treatment, so doctors follow patients for a long time, often using blood markers like inhibin B and anti-Müllerian hormone. The adult type carries a characteristic gene change (FOXL2) that helps pathologists confirm the diagnosis.
The main types
Doctors group granulosa cell tumor of the ovary by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Adult granulosa cell tumor | By far the most common type, usually in middle-aged or older women; carries a typical FOXL2 gene change and is known for late recurrences. |
| Juvenile granulosa cell tumor | A rarer type seen in children and young women; can cause early puberty, usually behaves well when found early, and tends to recur sooner rather than later if it does. |
Staging, in plain terms
Granulosa cell tumors use the same FIGO stages as other ovarian cancers to describe how far the tumor has spread. Stage at diagnosis is the strongest predictor of outcome, and most tumors are stage I — confined to one ovary — when found.
| Ovarian cancer FIGO staging | What it generally means |
|---|---|
| Stage I | Confined to one or both ovaries. The most common situation, usually cured by surgery, especially when the tumor capsule is intact. |
| Stage II | Spread to other structures within the pelvis. Less common; may prompt added treatment. |
| Stage III | Spread to the lining of the abdomen or to lymph nodes. Treated with surgery plus chemotherapy. |
| Stage IV | Spread to distant organs such as the liver or lungs. Uncommon at first diagnosis; managed with combined therapy at an expert center. |
The standard of care
Granulosa Cell Tumor of the Ovary is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the main treatment)
Removing the tumor is the cornerstone. For young women with an early, one-sided tumor, surgeons can often remove just the affected ovary and tube to preserve fertility; for others, more complete surgery with staging is done.
Chemotherapy
Reserved mainly for advanced, high-risk, or recurrent tumors — typically a platinum-based regimen — rather than for early disease that surgery has already cleared.
Hormone therapy
Because many of these tumors are sensitive to hormones, anti-hormone pills (such as aromatase inhibitors) can be used for recurrent or hard-to-remove disease.
Long-term monitoring
Blood markers (inhibin B, anti-Müllerian hormone) and imaging are followed for many years, because these tumors can return long after treatment.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. For granulosa cell tumors, surgery is the main treatment and radiation plays only a limited, selective role — for instance, controlling an isolated area of recurrence or easing symptoms. When it is used, it is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.
The main ways radiation is delivered for granulosa cell tumor of the ovary:
Radiation (selective)
Radiation is not a routine treatment for granulosa cell tumors; it is used in selected cases to control a specific area of recurrence or to relieve symptoms when surgery and other treatments are not enough.
Stereotactic / focused radiation
When recurrence shows up as one or a few isolated spots, precisely targeted high-dose radiation can control them while sparing nearby healthy tissue.
Palliative radiation
Short courses of radiation can ease pain, bleeding, or pressure symptoms from advanced, treatment-resistant disease.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
FOXL2 mutation defines the adult type: A specific FOXL2 gene change is found in nearly all adult granulosa cell tumors, giving pathologists a reliable way to confirm the diagnosis and opening the door to research on targeted treatments.[1]
Molecular pathology reviews of sex cord-stromal tumors (2021–2025)
Hormone-blocking therapy for recurrence: Aromatase inhibitors and other hormone-blocking drugs show meaningful activity in recurrent granulosa cell tumors, offering a well-tolerated option alongside or instead of chemotherapy.[2]
Gynecologic oncology treatment series (2022–2025)
The case for very long follow-up: Outcome studies confirm that recurrences can appear a decade or more after the original tumor, supporting extended surveillance with blood markers and imaging.[3]
Rare ovarian tumor outcome studies (2020–2024)
Common questions
Can I still have children after treatment? Often yes. For young women with an early, one-sided tumor, surgeons can frequently remove only the affected ovary and fallopian tube, leaving the uterus and other ovary in place. Your team will tailor the plan to your age, stage, and wishes.
Why do I need follow-up for so many years? Granulosa cell tumors are known for coming back long after the first treatment — sometimes a decade or more later. Regular check-ups with blood markers like inhibin B and imaging help catch any recurrence early, when it is most treatable.
Why am I having unusual bleeding? Many of these tumors make estrogen, which can thicken the uterine lining and cause irregular bleeding or bleeding after menopause. This is often the symptom that leads to diagnosis, and it usually settles after the tumor is removed.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Molecular pathology reviews of sex cord-stromal tumors (2021–2025) (no indexed identifier — see your care team) ↩
- Gynecologic oncology treatment series (2022–2025) (no indexed identifier — see your care team) ↩
- Rare ovarian tumor outcome studies (2020–2024) (no indexed identifier — see your care team) ↩